# BIOWEG

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/bioweg

- Industry: Biotechnology
- Headquarters: Germany
- Website: www.bioweg.com
- Total disclosed funding: $21M
- Latest round: Series A (Aug 31, 2026)
- Investors on record: 6

## About

Based in Germany, and Co-founded in 2019 as Cellulosic Technologies (now BIOWEG) by (CEO) Dr. Prateek Mahalwar and (COO) Srinivas Karuturi , BIOWEG GmbH develops bio-based ingredients and biotechnology solutions for the food, beverage, nutraceutical, personal care, and cosmetics industries. In September 2026, BIOWEG GmbH raised EUR 2 million in Series A funding from Rabo Investments. The investment formed part of a larger EUR 14 million Series A and grant funding round.
BIOWEG develops bio-based ingredients for the food, beverage, nutraceutical, personal care, and cosmetics industries. Its product portfolio includes microbial cellulose-based ingredients used as rheology modifiers, stabilizers, texturizers, and functional ingredients, developed through biotechnology, material science, and molecular simulation technologies.
The company revenue is generated through the development, manufacture, and sale of bio-based ingredients for food, beverage, nutraceutical, personal care, and cosmetics companies. Revenue is derived from supplying microbial cellulose-based ingredients and related biotechnology solutions to commercial customers.
The company plans to use the September 2026 funding to expand bacterial cellulose production capacity, support commercial rollout, and develop its manufacturing facility in Elsdorf.

## Funding rounds

- Series A, Aug 31, 2026, $2.3M — Rabo Investments
- Series A, Jul 22, 2025, $19M — BONVENTURE, Ginkgo BioWorks, Inc., Axeleo, European Innovation Council, NBank Capital

## Investors

- BONVENTURE (https://capitalatlas.ai/funds/bonventure) — Series A
- Ginkgo BioWorks, Inc. — Series A
- Axeleo (https://capitalatlas.ai/funds/axeleo) — Series A
- European Innovation Council (https://capitalatlas.ai/funds/european-innovation-council) — Series A
- NBank Capital (https://capitalatlas.ai/funds/nbank-capital) — Series A
- Rabo Investments (https://capitalatlas.ai/funds/rabo-investments) — Series A